Vivos Therapeutics Stock In The News
| VVOS Stock | USD 3.30 0.14 4.43% |
Our overall analysis of Vivos Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Vivos Therapeutics. The specific impact of Vivos Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Vivos Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Vivos Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Vivos Therapeutics Backtesting and Vivos Therapeutics Hype Analysis. For more information on how to buy Vivos Stock please use our How to Invest in Vivos Therapeutics guide.
Vivos |
Vivos Therapeutics Today Top News and Investor Outlook
Vivos Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Vivos and other traded companies coverage with news coverage. We help investors stay connected with Vivos headlines for the 14th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Vivos Stock performance. Please note that trading solely based on the Vivos Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Vivos Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Vivos earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Vivos Therapeutics that are available to investors today. That information is available publicly through Vivos media outlets and privately through word of mouth or via Vivos internal channels. However, regardless of the origin, that massive amount of Vivos data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Vivos Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Vivos Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Vivos Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Vivos Therapeutics alpha.
Vivos Largest EPS Surprises
Earnings surprises can significantly impact Vivos Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-05-17 | 2021-03-31 | -0.17 | -0.19 | -0.02 | 11 | ||
2022-08-15 | 2022-06-30 | -0.25 | -0.28 | -0.03 | 12 | ||
2023-08-16 | 2023-06-30 | -0.14 | -0.18 | -0.04 | 28 | ||
2022-12-20 | 2022-09-30 | -0.28 | -0.33 | -0.05 | 17 | ||
2021-11-15 | 2021-09-30 | -0.18 | -0.26 | -0.08 | 44 | ||
2022-03-31 | 2021-12-31 | -0.25 | -0.34 | -0.09 | 36 |
Vivos Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Vivos Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
3rd of March 2025
Acquisition by Bradford Amman of 200000 shares of Vivos Therapeutics at 0.48 subject to Ru... at MacroaxisInsider
24th of February 2025
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center ... at gurufocus.com
12th of February 2025
Vivos Therapeutics announces up to 50M mixed shelf offering - MSN at news.google.com
8th of January 2025
Best Momentum Stocks To Buy For January 8th - Barchart at news.google.com
23rd of December 2024
Vivos Therapeutics Announces 3.5 Million Registered Direct Offering Priced At-the-Market U... at gurufocus.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vivos Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vivos Therapeutics' short interest history, or implied volatility extrapolated from Vivos Therapeutics options trading.
Additional Tools for Vivos Stock Analysis
When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.